-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
Distributors in China and Japan have each maintained exclusive distribution agreements with the Company for over 10 years and collectively accounted for 46% of the Company's total international revenue in 2023
HORSHAM, Pa., April 09, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces the renewal of two distinct distribution agreements in international territories – one with the current exclusive distributor in China and a second with the current exclusive distributor in Japan. Terms of each of the distribution agreements are for three years and carry minimum unit placements and/or purchases of the XTRAC and VTRAC devices.
"The renewal of these exclusive distribution agreements in China and Japan, when coupled with the renewal of the distribution agreement in South Korea announced in December 2023, brings improved visibility to the international segment of our business," stated Dr. Dolev Rafaeli, STRATA's President and Chief Executive Officer. "International revenue in 2023 was nearly a third of our total revenue, and as we focus on additional opportunities for growth outside of the U.S., we are gratified that our long-standing exclusive distributors in these three key territories continue to provide value through our innovative product offerings in their respective dermatology markets. We look forward to continued mutually beneficial relations with each and leveraging our installed base around the world, as service and parts sales are an important aspect of our international business."
Distributors in China and Japan have each maintained exclusive distribution agreements with the Company for over 10 years and collectively accounted for 46% of the Company's total international revenue in 2023
中国和日本的分销商均与公司签订了超过10年的独家分销协议,合计占公司2023年国际总收入的46%
HORSHAM, Pa., April 09, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces the renewal of two distinct distribution agreements in international territories – one with the current exclusive distributor in China and a second with the current exclusive distributor in Japan. Terms of each of the distribution agreements are for three years and carry minimum unit placements and/or purchases of the XTRAC and VTRAC devices.
宾夕法尼亚州霍舍姆,2024年4月9日(GLOBE NEWSWIRE)——致力于开发、商业化和营销用于治疗皮肤病的创新产品的医疗技术公司STRATA Skin Sciences, Inc.(“STRATA” 或 “公司”)(纳斯达克股票代码:SSKN)宣布在国际地区续订两项不同的分销协议——一项与目前的中国独家分销商续订在日本。每份分销协议的条款均为三年,包括XTRAC和VTRAC设备的最低单位投放和/或购买。
"The renewal of these exclusive distribution agreements in China and Japan, when coupled with the renewal of the distribution agreement in South Korea announced in December 2023, brings improved visibility to the international segment of our business," stated Dr. Dolev Rafaeli, STRATA's President and Chief Executive Officer. "International revenue in 2023 was nearly a third of our total revenue, and as we focus on additional opportunities for growth outside of the U.S., we are gratified that our long-standing exclusive distributors in these three key territories continue to provide value through our innovative product offerings in their respective dermatology markets. We look forward to continued mutually beneficial relations with each and leveraging our installed base around the world, as service and parts sales are an important aspect of our international business."
STRATA总裁兼首席执行官多列夫·拉斐利博士表示:“在中国和日本续订这些独家分销协议,加上2023年12月宣布续订的韩国分销协议,提高了我们国际业务的知名度。”“2023年的国际收入占我们总收入的近三分之一,随着我们专注于美国以外的更多增长机会,我们对我们在这三个关键领域的长期独家分销商继续通过我们在各自的皮肤科市场提供的创新产品提供价值感到高兴。我们期待与双方继续保持互利关系,并充分利用我们在全球的安装基础,因为服务和零件销售是我们国际业务的重要方面。”
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧